drugset / Trial / NCT00322283
Study of Oglemilast for the Prevention of Asthma.
Non-randomizedCrossoverTriple-blindPrevention
Summary
The purpose of this study is to determine whether it is effective in the treatment of exercise-induced asthma and investigate the safety of oglemilast.
Timeline
- Start
- 2006-05
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oglemilast | Small molecule | 15 mg | Oral |